Skip to content

FP7H2020HORIZON

Fondazione Telethon Ets

Country
ITItaly
Defence projects
0
Projects, all programmes
59
As coordinator
29
EU contribution (CORDIS)
EUR 47,915,079
Active
2008 to 2025

Projects

59 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
LYSOCILExcel in Rare Diseases’ Research: Focus on LYSOsomal Disorders and CILiopathiesH20202018ParticipantEUR 183,069
BONEPHAGYDefining the role of the FGF – autophagy axis in bone physiologyH20202017CoordinatorEUR 1,586,430
EYEGETGene therapy of inherited retinal diseasesH20202017CoordinatorEUR 2,364,315
LysoModGenetic and Small Molecule Modifiers of Lysosomal FunctionH20202017ParticipantEUR 0
GeneVisionDeveloping a cure for retinitis pigmentosa due to Usher syndromeH20202017CoordinatorEUR 150,000
COSY-BIOControl Engineering of Biological Systems for Reliable Synthetic Biology ApplicationsH20202017CoordinatorEUR 555,875
REBuILDExploring the role of TFEB in exosome biology and in novel approaches for treatment of lysosomal diseasesH20202016CoordinatorEUR 180,277
LYSOSOMICSFunctional Genomics of the LysosomeH20202016CoordinatorEUR 2,362,563
SYSMETSystems Biology of Membrane TraffickingH20202016CoordinatorEUR 2,241,250
BATCureDeveloping new therapies for Batten diseaseH20202016ParticipantEUR 566,248
INCIPITINnovative Life sCIence Phd Programme in South ITalyH20202016PartnerEUR 0
.BLASTED2Identification of molecular targets for the treatment of the skeletal phenotype in Lysosomal Storage DisordersH20202014CoordinatorEUR 100,000
ALLELECHOKERDNA binding proteins for treatment of gain of function mutationsFP72013CoordinatorEUR 1,354,840
NANOSOLUTIONSBiological Foundation for the Safety Classification of Engineered Nanomaterials (ENM): Systems Biology Approaches to Understand Interactions of ENM with Living Organisms and the EnvironmentFP72013ParticipantEUR 249,997
EYETNBeyond the Genome; training the next generation of ophthalmic researchersFP72012ParticipantEUR 282,524
MEUSIXClinical trial of gene therapy for MPS VI - a severe lysosomal storage disorderFP72012CoordinatorEUR 1,790,560
IEMTXTherapies for inborn errors of metabolismFP72012CoordinatorEUR 1,491,520
RETGENTXOvercoming the challenge of large gene transfer for the therapy of inherited retinal diseasesFP72012CoordinatorEUR 1,500,000
DTI-IMPORTDULBECCO TELETHON INSTITUTE-INTERNATIONAL MOBILITY FOR POSTDOCTORAL RESEARCH TRAININGFP72012CoordinatorEUR 2,194,163
MUSCLEANDCANCERSearch for novel molecules cross-talking between muscle and cancer with therapeutic potential against cachexia and cancerFP72012ParticipantNot stated

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.